Mesenchymal Stromal Cell Exosomes in Cardiac Repair.
Darukeshwara JoladarashiRaj KishorePublished in: Current cardiology reports (2022)
The recent revolutionary advance in controlling the contents of the exosomes by manipulating parental cells through bioengineering methods to alter specific signaling pathways in ischemic myocardium has proven to be beneficial in the treatment of heart failure. MSC Exosomes appear to be leading candidates to treat myocardial infarction and subsequent heart failure by carrying rich cargo from their parental cells. However, more clinical and pre-clinical studies on MSC exosomes will be required to confirm the beneficial effect to treat cardiovascular diseases.
Keyphrases
- heart failure
- mesenchymal stem cells
- induced apoptosis
- stem cells
- left ventricular
- cell cycle arrest
- bone marrow
- signaling pathway
- cardiovascular disease
- endoplasmic reticulum stress
- cell therapy
- oxidative stress
- atrial fibrillation
- type diabetes
- cell death
- acute heart failure
- metabolic syndrome
- cardiovascular risk factors
- blood brain barrier
- cerebral ischemia